Evidence map›Paper›PMID 42665685›Full record

ArticleNature biotechnology2026

Precise genomic integration of large DNA fragments by donor-directed annealing using prime editing.

Hojun Jung, Bada Jeong, Yong-Woo Kim, Chanju Jung, Seoho Lee, Heesoo Uhm, Hyoungrak Kim, Ye Eun Oh, Yoonseo Park, Yeji Lee and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Hojun Jung *Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
Bada Jeong *Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.ORCID http://orcid.org/0009-0003-0805-2825
Yong-Woo Kim *Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
Chanju JungDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
Seoho LeeDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.ORCID http://orcid.org/0009-0008-3167-0492
Heesoo UhmGenomic Medicine Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0001-8993-3955
Hyoungrak KimDepartment of Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Ye Eun OhDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
Yoonseo ParkDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.ORCID http://orcid.org/0009-0009-0906-1719
Yeji LeeInstitute of Molecular Biology and Genetics, Seoul National University, Seoul, Republic of Korea.ORCID http://orcid.org/0009-0003-1100-4234
Miseung KangDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
Hyeon Woo ImDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
Doyoon KimDepartment of MetaBioHealth, School of Medicine, Sungkyunkwan University, Suwon, Republic of Korea.
Soyoon LeeDepartment of MetaBioHealth, School of Medicine, Sungkyunkwan University, Suwon, Republic of Korea.ORCID http://orcid.org/0009-0008-7586-8468
Yohan KimDepartment of MetaBioHealth, School of Medicine, Sungkyunkwan University, Suwon, Republic of Korea.ORCID http://orcid.org/0000-0002-4009-1694
Kyungho ChoiDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0003-1635-173X
Sangsu BaeDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea. sbae7@snu.ac.kr.ORCID http://orcid.org/0000-0003-3615-8566

Funding

National Research Foundation of Korea (NRF) 2021M3A9H3015389
6 · The paper itself

Abstract

Replacing large-scale fragments in human cells remains a substantial challenge. Here, we present a programmable gene replacement tool, named prime assembly (PA), which adapts prime editors to produce one or two pairs of 3'-flaps on both the genome and donor DNA. These 3'-flaps anneal to each other precisely, similar to Gibson assembly in DNA oligonucleotides, allowing megabase-scale genomic excision and/or kilobase-scale donor insertion at the gene of interest. PA accepts DNA plasmids and linear double-stranded DNA as donors, ranging from 1.0 to 6.5 kb in size. We demonstrate an efficiency of up to 57.8% in replacing endogenous sequences with a 2.9-kb donor DNA fragment in HEK293T cells, with an accuracy of >90% for integrated PA fragments. Furthermore, PA enables site-specific chimeric antigen receptor integration with up to 28.1% efficiency in primary human T cells. When PA containing a GFP donor is delivered to mice by hydrodynamic injection, an average integration efficiency of 4.3% is measured in GFP-positive hepatocytes.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.